DaVita Other Current Assets 2010-2024 | DVA

DaVita other current assets from 2010 to 2024. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • DaVita other current assets for the quarter ending September 30, 2024 were $M, a NAN% increase year-over-year.
  • DaVita other current assets for 2023 were $0B, a NAN% decline from 2022.
  • DaVita other current assets for 2022 were $0B, a NAN% decline from 2021.
  • DaVita other current assets for 2021 were $0B, a NAN% decline from 2020.
DaVita Annual Other Current Assets
(Millions of US $)
2023 $
2022 $
2021 $
2020 $
2019 $
2018 $5,390
2017 $5,762
2016 $961
2015 $190
2014 $187
2013 $176
2012 $202
2011 $49
2010 $44
2009 $40
DaVita Quarterly Other Current Assets
(Millions of US $)
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31
2021-09-30
2021-06-30
2021-03-31
2020-12-31
2020-09-30
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31 $6,005
2018-12-31 $5,390
2018-09-30 $5,948
2018-06-30 $6,053
2018-03-31 $5,724
2017-12-31 $5,762
2017-09-30 $205
2017-06-30 $202
2017-03-31 $204
2016-12-31 $961
2016-09-30 $177
2016-06-30 $188
2016-03-31 $187
2015-12-31 $190
2015-09-30 $176
2015-06-30 $190
2015-03-31 $186
2014-12-31 $187
2014-09-30 $172
2014-06-30 $165
2014-03-31 $170
2013-12-31 $176
2013-09-30 $157
2013-06-30 $150
2013-03-31 $150
2012-12-31 $202
2012-09-30 $47
2012-06-30 $46
2012-03-31 $47
2011-12-31 $49
2011-09-30 $67
2011-06-30 $50
2011-03-31 $46
2010-12-31 $44
2010-09-30 $39
2010-06-30 $39
2010-03-31 $34
2009-12-31 $40
2009-09-30 $35
2009-06-30 $38
2009-03-31 $32
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $12.272B $12.140B
DaVita Inc. is a leading provider of dialysis services in the U.S. to patients suffering from chronic kidney failure, also known as end-stage renal disease (ESRD). The company operates kidney dialysis centers and provides related medical services primarily in dialysis centers and in contracted hospitals across the U.S. Its services include outpatient dialysis services, hospital inpatient dialysis services and ancillary services such as ESRD laboratory services and disease management services. DaVita's Dialysis and related lab services business segment provides inpatient as well as outpatient dialysis services, routine laboratory testing for ESRD patients and management services to outpatient dialysis centers. The company's other ancillary services and strategic initiatives segment includes its international dialysis services, pharmacy services, infusion therapy services, disease management services, vascular access services, ESRD clinical research programs and physician services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $20.419B 12.35
Quest Diagnostics (DGX) United States $17.788B 18.03
Encompass Health (EHC) United States $10.397B 24.51
Chemed (CHE) United States $8.402B 25.82
Elanco Animal Health (ELAN) United States $6.955B 16.55
RadNet (RDNT) United States $5.364B 127.25
Option Care Health (OPCH) United States $3.826B 18.13
Amedisys (AMED) United States $3.166B 22.54
LifeStance Health (LFST) United States $2.816B 0.00
Addus HomeCare (ADUS) United States $2.313B 27.14
Astrana Health (ASTH) United States $2.305B 36.12
U.S Physical Therapy (USPH) United States $1.434B 37.73
Pennant (PNTG) United States $1.148B 46.42
Aveanna Healthcare Holdings (AVAH) United States $1.127B 0.00
Atai Life Sciences (ATAI) Germany $0.237B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.014B 0.00
Psychemedics (PMD) United States $0.014B 0.00
ATI Physical Therapy (ATIP) United States $0.011B 0.00
Ontrak (OTRK) United States $0.008B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00